NO20060392L - Kombinasjon av SRC kinase inhibitorer kemoterapeutiske midler for behandling av proliferative sykdommer - Google Patents

Kombinasjon av SRC kinase inhibitorer kemoterapeutiske midler for behandling av proliferative sykdommer

Info

Publication number: NO20060392L
Authority: NO; Norway
Prior art keywords: treatment; combination; chemotherapeutic agents; kinase inhibitors; proliferative diseases
Prior art date: 2003-07-09

Application number

NO20060392A

Other languages

English (en)

Norwegian (no)

Inventor

Francis Y F Lee

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-09

Filing date

2006-01-24

Publication date

2006-02-03

2006-01-24 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2006-02-03 Publication of NO20060392L publication Critical patent/NO20060392L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

NO20060392A 2003-07-09 2006-01-24 Kombinasjon av SRC kinase inhibitorer kemoterapeutiske midler for behandling av proliferative sykdommer NO20060392L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US48577903P	2003-07-09	2003-07-09
PCT/US2004/021890 WO2005013983A1 (en)	2003-07-09	2004-07-09	Combination of src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases

Publications (1)

Publication Number	Publication Date
NO20060392L true NO20060392L (no)	2006-02-03

Family

ID=34135068

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20060392A NO20060392L (no)	2003-07-09	2006-01-24	Kombinasjon av SRC kinase inhibitorer kemoterapeutiske midler for behandling av proliferative sykdommer

Country Status (20)

Country	Link
US (2)	US20050009891A1 (sr)
EP (1)	EP1643996A4 (sr)
JP (1)	JP2007528849A (sr)
KR (1)	KR20060032627A (sr)
CN (1)	CN1849119A (sr)
AU (1)	AU2004263095B2 (sr)
BR (1)	BRPI0411864A (sr)
CA (1)	CA2531675A1 (sr)
GE (1)	GEP20094677B (sr)
IL (1)	IL173008A0 (sr)
IS (1)	IS8221A (sr)
MX (1)	MXPA06000191A (sr)
NO (1)	NO20060392L (sr)
NZ (1)	NZ544587A (sr)
RS (1)	RS20060011A (sr)
RU (1)	RU2006103858A (sr)
TW (1)	TW200505443A (sr)
UA (1)	UA83850C2 (sr)
WO (1)	WO2005013983A1 (sr)
ZA (1)	ZA200600176B (sr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0202708A3 (en)	1999-04-15	2004-12-28	Bristol Myers Squibb Co	Cyclic protein tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
US7491725B2 (en)	2004-02-06	2009-02-17	Bristol-Myers Squibb Company	Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
BRPI0510095A (pt) *	2004-04-20	2007-10-16	Transtech Pharma Inc	tiazol substituìdo e derivados de pirimidina como moduladores de receptores de melanocortina
TW200628156A (en) *	2004-11-04	2006-08-16	Bristol Myers Squibb Co	Combination of a SRC kinase inhibitor and a BCR-ABL inhibitor for the treatment of proliferative diseases
PE20061394A1 (es) *	2005-03-15	2006-12-15	Bristol Myers Squibb Co	Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas
US20060235006A1 (en) *	2005-04-13	2006-10-19	Lee Francis Y	Combinations, methods and compositions for treating cancer
CA2610157A1 (en) *	2005-06-09	2006-12-21	Bristol-Myers Squibb Company	Methods of identifying and treating individuals exhibiting mutant kit protein
EP1937270A1 (en) *	2005-09-21	2008-07-02	Brystol-Myers Squibb Company	Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
US20070093499A1 (en) *	2005-10-20	2007-04-26	Bristol-Myers Squibb Company	Use of dasatinib for the treatment of bone metastasis
WO2007059143A2 (en) *	2005-11-15	2007-05-24	Bristol-Myers Squibb Company	Methods of identifying and treating individuals exhibiting mdr-1 overexpression with protein tyrosine kinase inhibitors and combinations thereof
US20090306094A1 (en) *	2006-03-17	2009-12-10	Bristol-Myers Squibb Company	Methods Of Identifying And Treating Individuals Exhibiting Mutant Bcr/Abl Kinase Polypeptides
CN101583365B (zh) *	2006-12-15	2012-09-26	阿布拉西斯生物科学公司	三嗪衍生物及其治疗应用
GB0625691D0 (en) *	2006-12-22	2007-01-31	Astrazeneca Ab	Combination product
CN101265274B (zh) *	2007-02-16	2013-09-04	中国医学科学院药物研究所	嘧啶噻唑胺衍生物、及其制法和药物组合物与用途
US8119129B2 (en)	2008-08-01	2012-02-21	Bristol-Myers Squibb Company	Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases
WO2010025142A1 (en) *	2008-08-29	2010-03-04	Transtech Pharma, Inc.	Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
MX2012000851A (es) *	2009-07-20	2012-06-08	Squibb Bristol Myers Co	Combinacion de anticuerpo de anti-antigeno 4 asociado al linfocito t citotoxico con diversos regimenes terapeuticos para tratamiento sinergistico de enfermedades proliferativas.
BR112014032346A2 (pt)	2012-06-26	2017-06-27	Del Mar Pharmaceuticals	métodos para tratamento de malignidades resistentes ao inibidor de tirosina-quinase em pacientes com polimorfismos genéticos ou desregulações de ahi1 mutações empregando dianidrogalactitol, diacetildianidrogalactitol, dibromodulcitol, ou análogos ou derivados destes
CN115192540A (zh)	2018-06-15	2022-10-18	汉达癌症医药责任有限公司	激酶抑制剂的盐类及其组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5051910A (en) *	1989-10-16	1991-09-24	Honeywell Inc.	Wind forecast error compensation for 4-D guidance in a aircraft flight management system
US5121325A (en) *	1990-04-04	1992-06-09	Smiths Industries Aerospace & Defense Systems, Inc.	Required time of arrival (RTA) control system
ZA200007412B (en) *	1998-05-15	2002-03-12	Imclone Systems Inc	Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
US7125875B2 (en)	1999-04-15	2006-10-24	Bristol-Myers Squibb Company	Cyclic protein tyrosine kinase inhibitors
HUP0202708A3 (en) *	1999-04-15	2004-12-28	Bristol Myers Squibb Co	Cyclic protein tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
US6507782B1 (en) *	2001-05-14	2003-01-14	Honeywell International Inc.	Aircraft control system for reaching a waypoint at a required time of arrival
JP2005502643A (ja)	2001-08-10	2005-01-27	ノバルティス　アクチエンゲゼルシャフト	白血病処置のための単独またはｓｔｉ５７１と組み合せたｃ−ｓｒｃインヒビターの使用
US20040209930A1 (en)	2002-10-02	2004-10-21	Carboni Joan M.	Synergistic methods and compositions for treating cancer
US20050215795A1 (en)	2004-02-06	2005-09-29	Bang-Chi Chen	Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US7652146B2 (en) *	2004-02-06	2010-01-26	Bristol-Myers Squibb Company	Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors

2004
- 2004-07-08 US US10/886,955 patent/US20050009891A1/en not_active Abandoned
- 2004-07-09 RS YUP-2006/0011A patent/RS20060011A/sr unknown
- 2004-07-09 RU RU2006103858/04A patent/RU2006103858A/ru not_active Application Discontinuation
- 2004-07-09 WO PCT/US2004/021890 patent/WO2005013983A1/en not_active Ceased
- 2004-07-09 GE GEAP20049207A patent/GEP20094677B/en unknown
- 2004-07-09 UA UAA200601309A patent/UA83850C2/ru unknown
- 2004-07-09 EP EP04777765A patent/EP1643996A4/en not_active Withdrawn
- 2004-07-09 CN CNA2004800259078A patent/CN1849119A/zh active Pending
- 2004-07-09 TW TW093120688A patent/TW200505443A/zh unknown
- 2004-07-09 NZ NZ544587A patent/NZ544587A/en unknown
- 2004-07-09 KR KR1020067000300A patent/KR20060032627A/ko not_active Ceased
- 2004-07-09 JP JP2006518903A patent/JP2007528849A/ja active Pending
- 2004-07-09 AU AU2004263095A patent/AU2004263095B2/en not_active Ceased
- 2004-07-09 CA CA002531675A patent/CA2531675A1/en not_active Abandoned
- 2004-07-09 MX MXPA06000191A patent/MXPA06000191A/es not_active Application Discontinuation
- 2004-07-09 BR BRPI0411864-2A patent/BRPI0411864A/pt not_active IP Right Cessation
2006
- 2006-01-06 IS IS8221A patent/IS8221A/is unknown
- 2006-01-06 ZA ZA200600176A patent/ZA200600176B/xx unknown
- 2006-01-08 IL IL173008A patent/IL173008A0/en unknown
- 2006-01-24 NO NO20060392A patent/NO20060392L/no not_active Application Discontinuation
2008
- 2008-03-13 US US12/047,623 patent/US7622472B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7622472B2 (en)	2009-11-24
JP2007528849A (ja)	2007-10-18
NZ544587A (en)	2009-07-31
AU2004263095B2 (en)	2009-10-29
WO2005013983A1 (en)	2005-02-17
ZA200600176B (en)	2010-06-30
TW200505443A (en)	2005-02-16
US20080153842A1 (en)	2008-06-26
CN1849119A (zh)	2006-10-18
KR20060032627A (ko)	2006-04-17
CA2531675A1 (en)	2005-02-17
RU2006103858A (ru)	2006-06-27
IL173008A0 (en)	2006-06-11
AU2004263095A1 (en)	2005-02-17
UA83850C2 (ru)	2008-08-26
BRPI0411864A (pt)	2006-08-08
RS20060011A (sr)	2007-12-31
IS8221A (is)	2006-01-06
GEP20094677B (en)	2009-05-10
EP1643996A1 (en)	2006-04-12
US20050009891A1 (en)	2005-01-13
EP1643996A4 (en)	2009-06-03
MXPA06000191A (es)	2006-04-11

Publication	Publication Date	Title
NO20060392L (no)	2006-02-03	Kombinasjon av SRC kinase inhibitorer kemoterapeutiske midler for behandling av proliferative sykdommer
NO20034056L (no)	2003-11-05	Kombinasjoner av epotilonanaloger og kjemoterapeutiske midler for behandling av proliferative sykdommer
NO20082880L (no)	2008-09-01	Inhibitorer av C-MET samt anvendelse derav
TW200801008A (en)	2008-01-01	Protein kinase inhibitors
NO20085373L (no)	2005-11-29	P38 inhibitorer, deres fremstilling og anvendelse
NO20055894L (no)	2006-03-21	Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
EA200900802A1 (ru)	2010-04-30	Способы и композиции для лечения амилоидных заболеваний
NO20072567L (no)	2007-07-17	Triazoler nyttige som proteinkinase-inhibitorer
EA200700333A1 (ru)	2007-10-26	Терапевтические применения ингибиторов rtp801
NO20072179L (no)	2007-05-31	Kombinasjon av en SRC kinase inhibitor og en. BCR-ABL inhibitor for behandling av proleferative sykdommer
NO20082026L (no)	2008-06-25	Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
DK1934174T3 (da)	2011-08-01	Azetidiner som MEK inhibitorer til behandling af proliferative sygdomme
NO20070866L (no)	2007-04-13	Antivirale forbindelser.
NO20085135L (no)	2009-01-12	Selektive inhibitorer av ROCK-proteinkinase og anvendelse derav
WO2003065987A3 (en)	2004-02-19	Granzyme b inhibitors
DK1641803T3 (da)	2009-06-29	Thienopyrimidinderivater som kaliumkanalinhibitorer
MX2021013602A (es)	2022-04-06	Inhibidores de jak.
WO2007050793A3 (en)	2008-01-24	Methods and compositions for the treatment of marfan syndrome and associated disorders
WO2005007123A3 (en)	2006-02-16	Pin1-modulating compounds and methods of use thereof
DK1575590T3 (da)	2008-02-11	Carbostyrilderivater og serotoningenoptagelsesinhibitorer til behandling af sindsstemningslidelser
NO20073725L (no)	2007-09-05	CCI-779-polymorf og dens anvendelse
ATE443044T1 (de)	2009-10-15	Tace inhibitoren
WO2007016338A3 (en)	2007-12-21	Use of chk2 kinase inhibitors for cancer treatment
TW200716561A (en)	2007-05-01	P38 inhibitors and methods of use thereof
MX2022001702A (es)	2022-04-20	Inhibidores de jak.

Legal Events

Date	Code	Title	Description
2012-02-20	FC2A	Withdrawal, rejection or dismissal of laid open patent application